These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 6152280

  • 1. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
    [Abstract] [Full Text] [Related]

  • 2. Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    J Cardiovasc Pharmacol; 1987 Oct; 10 Suppl 11():S97-100. PubMed ID: 2454378
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R.
    Acta Med Scand Suppl; 1984 Oct; 689():1-46. PubMed ID: 6151343
    [Abstract] [Full Text] [Related]

  • 5. Hemodynamic effects of combined beta-adrenoceptor blockade and precapillary vasodilatation in hypertension.
    Eggertsen R, Sivertsson R, Andrén L, Hansson L.
    Acta Med Scand Suppl; 1985 Oct; 693():115-20. PubMed ID: 2859739
    [Abstract] [Full Text] [Related]

  • 6. Effect of carvedilol and metoprolol on blood pressure, blood flow, and vascular resistance.
    Morgan T, Snowden R, Butcher L.
    J Cardiovasc Pharmacol; 1987 Oct; 10 Suppl 11():S124-9. PubMed ID: 2454358
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of perindopril and carvedilol on endothelium-dependent vascular functions in patients with diabetes and hypertension.
    Giugliano D, Marfella R, Acampora R, Giunta R, Coppola L, D'Onofrio F.
    Diabetes Care; 1998 Apr; 21(4):631-6. PubMed ID: 9571355
    [Abstract] [Full Text] [Related]

  • 9. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
    Abshagen U.
    J Cardiovasc Pharmacol; 1987 Apr; 10 Suppl 11():S23-32. PubMed ID: 2454364
    [Abstract] [Full Text] [Related]

  • 10. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B, Bompart F, Graham BR, Liu JB, Prichard BN.
    Drugs; 1988 Apr; 36 Suppl 6():37-47. PubMed ID: 2908303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the hemodynamic effects of metoprolol and carvedilol in hypertensive patients.
    Weber K, Bohmeke T, van der Does R, Taylor SH.
    Cardiovasc Drugs Ther; 1996 May; 10(2):113-7. PubMed ID: 8842502
    [Abstract] [Full Text] [Related]

  • 13. Effect of carvedilol on ambulatory blood pressure, renal hemodynamics, and cardiac function in essential hypertension.
    Dupont AG, Van der Niepen P, Taeymans Y, Ingels M, Piepsz A, Bossuyt AM, Block P, Six RO, Jonckheer MH, Vanhaelst L.
    J Cardiovasc Pharmacol; 1987 May; 10 Suppl 11():S130-6. PubMed ID: 2454359
    [Abstract] [Full Text] [Related]

  • 14. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
    Wendt T, van der Does R, Schräder R, Landgraf H, Kober G.
    J Cardiovasc Pharmacol; 1987 May; 10 Suppl 11():S147-50. PubMed ID: 2454362
    [Abstract] [Full Text] [Related]

  • 15. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P, Omvik P, Nordrehaug JE, White W.
    J Cardiovasc Pharmacol; 1992 May; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [Abstract] [Full Text] [Related]

  • 16. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R, Moitinho E, Piqueras B, Casado M, García-Pagán JC, de Diego A, Bosch J.
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic profile of carvedilol.
    van Zwieten PA.
    Cardiology; 1993 Jul; 82 Suppl 3():19-23. PubMed ID: 8106159
    [Abstract] [Full Text] [Related]

  • 18. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
    Giannattasio C, Cattaneo BM, Seravalle G, Carugo S, Mangoni AA, Grassi G, Zanchetti A, Mancia G.
    J Cardiovasc Pharmacol; 1992 Jul; 19 Suppl 1():S18-22. PubMed ID: 1378144
    [Abstract] [Full Text] [Related]

  • 19. Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol.
    Bril A, Slivjak M, DiMartino MJ, Feuerstein GZ, Linee P, Poyser RH, Ruffolo RR, Smith EF.
    Cardiovasc Res; 1992 May; 26(5):518-25. PubMed ID: 1359930
    [Abstract] [Full Text] [Related]

  • 20. Antihypertensive treatment with a vasodilating beta-blocker, carvedilol, in chronic hemodialysis patients.
    Deetjen A, Heidland A, Pangerl A, Meyer-Sabellek W, Schaefer RM.
    Clin Nephrol; 1995 Jan; 43(1):47-52. PubMed ID: 7697935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.